Recombinant Human Apo-2 Ligand for Injection

· Shanghai Gebaide Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Human Apo-2 Ligand for Injection, covering 2017-03-20 to 2017-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection [Phase 3]